Oxford BioDynamics Plc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OXBOF research report →
About the company
Headquartered in Oxford, United Kingdom, and established in 2007, Oxford BioDynamics Plc operates as a biotechnology enterprise. The company's primary focus lies in the discovery and development of biomarkers for the pharmaceutical and biotechnology industries, serving both domestic and international markets, with a significant presence in the United States. Central to its operations is EpiSwitch, a proprietary technology platform.
- CEO
- Iain Gladstone Ross
- IPO
- 2020
- Employees
- 51
- HQ
- Oxford, GB
Price Chart
- Market Cap
- $4.26M
- P/E
- -0.28
- P/S
- 1.96
- P/B
- 1.29
- EV/EBITDA
- -0.46
- Div Yield
- 0.00%
- Gross Margin
- -277.32%
- Op Margin
- -792.72%
- Net Margin
- -825.61%
- ROE
- -451.74%
- ROIC
- -114.20%
- Revenue
- $1.09M · 72.17%
- Net Income
- $-11,153,000 · 3.58%
- EPS
- $-0.01 · 82.22%
- Op Income
- $-11,074,000
- FCF YoY
- 27.40%
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.17
- Avg Volume
- 9.52K
Get TickerSpark's AI analysis on OXBOF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our OXBOF coverage
Recent articles, reports, and earnings notes.
No research on OXBOF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OXBOF report →Similar companies
Peers in the same neighborhood.